Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib in advanced GIST refractory to imatinib and sunitinib
2011-004404-37Phase 2Completed
- Sponsor
- Scandinavian Sarcoma Group
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pazopanib in gastrointestinal stromal tumor (GIST), sponsored by Scandinavian Sarcoma Group. Started Sep 2011; status: completed.
02
Drugs
pazopanib
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on 2011-004404-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004404-37.